GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Q2 FY27 Consolidated Net Profit INR 245.87 Million

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Nov 2026, 03:15 PM IST  ·  BSE ID: 1ec9479e-07cb-4552-a6f5-98f9da05c4e3
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its Q2 FY27 results, showing revenue of INR 2,709.69 Million and profit of INR 245.87 Million.
🤖 AI Summary
  • Krsnaa Diagnostics reported consolidated revenue from operations of INR 2,709.69 Million for Q2 FY27.
  • Consolidated profit for Q2 FY27 was INR 245.87 Million, up from INR 239.45 Million in Q2 FY26.
  • Basic earnings per equity share stood at INR 7.64 for the quarter ended September 30, 2026.
  • Total consolidated assets increased to INR 20,635.84 Million as of September 30, 2026.
  • The Board approved the unaudited standalone and consolidated financial results for the period.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
INR 2,709.69 Million
31.54
Profit for the period (Q2 FY27)
INR 258.17 Million
7.82
Profit attributable to Equity Holders (Q2 FY27)
INR 245.87 Million
2.68
Basic Earnings per equity share (Q2 FY27)
INR 7.64
3.52
Total Assets (September 30, 2026)
INR 20,635.84 Million
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to INR 2,709.69 Million in Q2 FY27 compared to INR 2,059.91 Million in Q2 FY26 indicates growth in the company's core diagnostics business.
💰
Financial Impact
Consolidated profit for the period rose to INR 245.87 Million, contributing to an increase in total equity to INR 10,386.39 Million as of September 30, 2026. Total assets also grew to INR 20,635.84 Million from INR 18,237.16 Million as of March 31, 2026.
⚠️
Risk Impact
The Income Tax Authorities' additions for undisclosed income and disallowance of certain deductions for AY 2017-18 to AY 2023-24, despite management's belief of immaterial impact, introduces an ongoing tax dispute risk. The company has deposited tax under protest amounting to Rs. 102.77 million and is appealing these orders.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's Q2 FY27 financial performance, including a basic EPS of INR 7.64 for the quarter, reflecting the profit attributable to equity holders.
🔍
Management Signal
The Board's approval of the financial results signals continuity in reporting and adherence to regulatory compliance, despite the ongoing tax assessment matters mentioned by auditors.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 results — assess sustained revenue and profit growth trends.
Updates on Income Tax appeals — monitor resolution of assessment proceedings.
Annual General Meeting (AGM) — review further management commentary on business strategy.
MEDIUM RISK The ongoing income tax assessment and appeals, while management deems the impact immaterial, present a notable financial risk.
💡 Investor Takeaway
Krsnaa Diagnostics reported consolidated revenue from operations of INR 2,709.69 Million for Q2 FY27, a 31.54% increase from INR 2,059.91 Million in Q2 FY26. Consolidated profit for the period was INR 245.87 Million. Basic EPS for Q2 FY27 was INR 7.64.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased by 31.54% to INR 2,709.69 Million in Q2 FY27 from INR 2,059.91 Million in Q2 FY26.
  • Profit for the period grew by 2.68% to INR 245.87 Million in Q2 FY27 compared to INR 239.45 Million in Q2 FY26.

⚠️ Concerns

  • Tax expense increased significantly by 7.43% to INR 81.81 Million in Q2 FY27 from INR 76.15 Million in Q2 FY26, impacting net profit growth.
  • The ongoing income tax assessment proceedings and related appeals for AY 2017-18 to AY 2023-24 involve a deposited tax of Rs. 102.77 million under protest.
📅 Company Track Record
Krsnaa Diagnostics Ltd's board met on November 02, 2026, to approve the Q2 and half-year FY27 results, as previously intimated on October 26, 2026. For Q2 FY26 (quarter ended September 30, 2025), the company reported revenue from operations of INR 2,059.91 Million and a profit for the period of INR 239.45 Million.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Krsnaa Diagnostics' consolidated revenue from operations in Q2 FY27?
Krsnaa Diagnostics reported consolidated revenue from operations of INR 2,709.69 Million for the quarter ended September 30, 2026 (Q2 FY27).
What was Krsnaa Diagnostics' consolidated net profit for Q2 FY27?
The consolidated profit attributable to Equity Holders for Krsnaa Diagnostics in Q2 FY27 was INR 245.87 Million.
What are the basic earnings per share (EPS) for Krsnaa Diagnostics in Q2 FY27?
Basic earnings per equity share (not annualised) for Krsnaa Diagnostics for Q2 FY27 stood at INR 7.64.
What was the total consolidated assets of Krsnaa Diagnostics as of September 30, 2026?
Total consolidated assets for Krsnaa Diagnostics were INR 20,635.84 Million as of September 30, 2026.
Has Krsnaa Diagnostics deposited any tax under protest related to income tax assessments?
Yes, Krsnaa Diagnostics has deposited tax under protest amounting to Rs. 102.77 million related to income tax assessment orders for AY 2017-18 to AY 2023-24.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.